PriceTargets.com logo

HTG Molecular Diagnostics - HTGM Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 06/14/2023 01:00 AM ET
+0 (0.00%)
Get New HTG Molecular Diagnostics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HTGM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HTGM

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for HTG Molecular Diagnostics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for HTGM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in HTG Molecular Diagnostics. This rating has held steady since March 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/23/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/19/2023HC WainwrightReiterated RatingBuy$6.00
4/3/2023HC WainwrightLower TargetBuy$15.00 ➝ $6.00
8/15/2022HC WainwrightLower TargetBuy$3.00 ➝ $2.00
7/22/2022Cantor FitzgeraldLower Target$15.00 ➝ $3.50
5/16/2022HC WainwrightLower TargetNA$4.00 ➝ $3.00
3/30/2022Cantor FitzgeraldReiterated RatingOverweight
3/30/2022HC WainwrightLower TargetBuy$9.00 ➝ $4.00
3/30/2022Craig HallumLower TargetBuy$8.00 ➝ $3.00
1/11/2022HC WainwrightReiterated RatingBuy$9.00
1/7/2022Craig HallumUpgradeHold ➝ Buy$5.00 ➝ $8.00
12/23/2021HC WainwrightReiterated RatingBuy$9.00
9/14/2021Leerink PartnersReiterated RatingBuy$10.00
7/21/2021HC WainwrightReiterated RatingBuy$9.00
5/20/2021HC WainwrightLower TargetBuy$11.00 ➝ $9.00
5/14/2021Leerink PartnersLower TargetOutperform$10.00
5/14/2021HC WainwrightLower TargetBuy$9.00
11/11/2020Leerink PartnersLower TargetOutperform$2.00 ➝ $1.00
8/5/2020HC WainwrightReiterated RatingBuy$1.00
6/19/2020HC WainwrightReiterated RatingBuy$1.00
6/12/2020HC WainwrightReiterated RatingBuy$1.00
5/14/2020HC WainwrightLower TargetBuy$1.50 ➝ $1.00
5/11/2020Cantor FitzgeraldReiterated RatingOverweight$2.00 ➝ $1.50
(Data available from 4/23/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/23/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/22/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
HTG Molecular Diagnostics logo
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $6.00
Low: $5.01
High: $6.80

52 Week Range

Now: N/A

Volume

773,040 shs

Average Volume

294,806 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of HTG Molecular Diagnostics?

The following sell-side analysts have issued stock ratings on HTG Molecular Diagnostics in the last year: StockNews.com.
View the latest analyst ratings for HTGM.

What is the current price target for HTG Molecular Diagnostics?

0 Wall Street analysts have set twelve-month price targets for HTG Molecular Diagnostics in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for HTG Molecular Diagnostics in the next year.
View the latest price targets for HTGM.

What is the current consensus analyst rating for HTG Molecular Diagnostics?

HTG Molecular Diagnostics currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for HTGM.

What other companies compete with HTG Molecular Diagnostics?

Other companies that are similar to HTG Molecular Diagnostics include HTG Molecular Diagnostics, Agilent Technologies, Mettler-Toledo International, Waters and Illumina. Learn More about companies similar to HTG Molecular Diagnostics.

How do I contact HTG Molecular Diagnostics' investor relations team?

HTG Molecular Diagnostics' physical mailing address is 3430 E. GLOBAL LOOP, TUCSON AZ, 85706. The medical research company's listed phone number is (520) 547-2827 and its investor relations email address is [email protected]. The official website for HTG Molecular Diagnostics is www.htgmolecular.com. Learn More about contacing HTG Molecular Diagnostics investor relations.